Free Trial

Henry Schein (HSIC) Stock Forecast & Price Target

$68.28
+2.10 (+3.17%)
(As of 06/18/2024 ET)

Henry Schein - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$81.73
19.69% Upside
High Forecast$96.00
Average Forecast$81.73
Low Forecast$65.00
TypeCurrent Forecast
6/20/23 to 6/19/24
1 Month Ago
5/21/23 to 5/20/24
3 Months Ago
3/22/23 to 3/21/24
1 Year Ago
6/20/22 to 6/20/23
Consensus Rating
Hold
Hold
Hold
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
3 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
3 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$81.73$81.73$81.09$86.14
Forecasted Upside19.69% Upside9.68% Upside8.89% Upside7.40% Upside
Get Henry Schein Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.

HSIC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HSIC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Henry Schein Stock vs. The Competition

TypeHenry ScheinMedical CompaniesS&P 500
Consensus Rating Score
2.36
2.70
2.50
Consensus RatingHoldModerate BuyHold
Predicted Upside19.69% Upside1,068.20% Upside11.30% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/8/2024Barrington Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$90.00 ➝ $92.00+26.10%
5/8/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$82.00 ➝ $80.00+11.42%
3/6/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$82.00 ➝ $88.00+15.59%
3/6/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$74.00 ➝ $81.00+7.41%
2/28/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetIn-Line ➝ In-Line$79.00 ➝ $83.00+9.40%
2/26/2024Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Cherny
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
2/26/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$78.00 ➝ $86.00+6.54%
2/26/2024SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$78.00-2.33%
11/27/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$75.00+9.91%
11/14/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$69.00 ➝ $65.00-3.90%
8/8/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$96.00+26.53%
8/7/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$76.00 ➝ $75.00-1.15%
11/1/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
B. Vazquez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
7/21/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$93.00 ➝ $85.00+8.97%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 07:53 AM ET.

HSIC Forecast - Frequently Asked Questions

What is Henry Schein's stock forecast and purchase recommendation?

According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Henry Schein is $81.73, with a high forecast of $96.00 and a low forecast of $65.00. The consensus rating for Henry Schein stock is Hold based on the current 1 sell rating, 5 hold ratings and 5 buy ratings for HSIC. Learn more on HSIC's analyst rating history.

Do Wall Street analysts like Henry Schein more than its competitors?

Analysts like Henry Schein less than other "medical" companies. The consensus rating for Henry Schein is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how HSIC compares to other companies.

Does Henry Schein's stock price have much upside?

According to analysts, Henry Schein's stock has a predicted upside of 9.68% based on their 12-month stock forecasts.

What analysts cover Henry Schein?

Henry Schein has been rated by research analysts at Barrington Research, and UBS Group in the past 90 days.


Stock Forecasts and Research Tools

This page (NASDAQ:HSIC) was last updated on 6/19/2024 by MarketBeat.com Staff

From Our Partners